Advertisement
Taking Action

Policy

  • The Impact of the RACE for Children Act

    Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.

    by Marci A. Landsmann

  • Policy Matters

    Patient Advocacy Is Driving Change

    FOR MORE THAN 25 YEARS,​ the American Association for Cancer Research (AACR) has been building bridges between cancer patient advocates and scientists through unique educational programs that foster communication. In October 2020, the AACR expanded its educational programming by introducing quarterly AACR Virtual Patient Advocate Forums. Available at no cost to patient advocates around the world, […]

    by Carrie Treadwell, MBA

  • Understanding Stress and Cancer

    A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.

    by Eric Fitzsimmons

  • February 4: The Week in Cancer News

    CAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.

    by Eric Fitzsimmons

  • Forward Look

    Adequate Representation

    Medical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.

    by Erin O'Donnell

  • Medicaid: A Partial Safety Net

    Expansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.

    by Sharon Tregaskis

  • December 3: The Week in Cancer News

    Some cancer centers scrutinized for lack of pricing transparency, and an imaging drug helps surgeons better identify ovarian cancer with fluorescent lighting.

    by Marci A. Landsmann

  • November 19: The Week in Cancer News

    HPV vaccine rates are higher when teens decide, and colorectal cancer is on the rise in people under 50.

    by Kevin McLaughlin

  • Policy Matters

    Cancer Research: The Key to Tomorrow’s Cures

    The AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.

    by David A. Tuveson, MD, PhD

  • Facts and Stats

    Fifty Years of Growing Survivorship

    More people in the U.S. are alive after being diagnosed with cancer than ever before.

    by Eric Fitzsimmons